Gene: MID1IP1
Official Full Name: MID1 interacting protein 1provided by HGNC
Gene Summary: Predicted to enable identical protein binding activity. Predicted to be involved in several processes, including negative regulation of microtubule depolymerization; positive regulation of fatty acid biosynthetic process; and positive regulation of ligase activity. Predicted to be located in microtubule cytoskeleton. Predicted to be active in cytosol. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO20874 | MID1IP1 Knockout cell line (HeLa) | Human | MID1IP1 | 1:3~1:6 | Negative | Online Inquiry |
KO20875 | MID1IP1 Knockout cell line (HCT 116) | Human | MID1IP1 | 1:2~1:4 | Negative | Online Inquiry |
KO20876 | MID1IP1 Knockout cell line (HEK293) | Human | MID1IP1 | 1:3~1:6 | Negative | Online Inquiry |
KO20877 | MID1IP1 Knockout cell line (A549) | Human | MID1IP1 | 1:3~1:4 | Negative | Online Inquiry |
MID1IP1 Gene Knockout Cell Lines are genetically modified cell lines specifically designed for the study of the MID1IP1 gene's function and its role in various biological processes. By utilizing CRISPR-Cas9 technology, these cell lines effectively eliminate the expression of the MID1IP1 gene, allowing researchers to explore the downstream effects of this knockout on cellular behavior, signaling pathways, and phenotypic outcomes.
The primary function of MID1IP1 knockout cell lines lies in their ability to facilitate investigations into the mechanistic roles of MID1IP1 in pathologies, particularly those related to neurodevelopmental disorders and cellular stress responses. By providing a platform to observe the absence of MID1IP1, researchers can delineate its involvement in key processes such as protein folding, cellular compartmentalization, and response to environmental stimuli. This deepened understanding can pave the way for novel therapeutic strategies targeting these pathways.
Scientifically, the MID1IP1 knockout cell lines hold significant importance in both research and clinical settings. They are crucial for elucidating the genetic and biochemical underpinnings of diseases associated with MID1IP1 dysregulation. Their application extends to drug discovery processes, where the validation of therapeutic candidates can be expedited through the use of these precise models that mimic human disease conditions.
Compared to traditional knockout strategies or silencing techniques, MID1IP1 knockout cell lines offer enhanced specificity and efficiency. The CRISPR-Cas9 method ensures a permanent and targeted knockout, minimizing off-target effects and providing more reliable data for researchers. Furthermore, these cell lines are derived from a variety of cellular contexts, enabling adaptability for diverse experimental needs.
For researchers, clinicians, and pharmaceutical developers, the MID1IP1 Gene Knockout Cell Lines represent a valuable tool for unraveling the complexities of gene function and its implications in health and disease. Furthermore, our company specializes in cutting-edge genetic engineering solutions, offering a wide range of customizable products and services to meet the demands of modern biological research. Our expertise in gene editing technologies ensures that our customers receive top-quality resources to accelerate their scientific achievements.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.